Nogo-A Mediated Endoplasmic Reticulum Stress During Myocardial Ischemic-Reperfusion Injury in Diabetic Rats

Among the three isoforms encoded by neurite outgrowth inhibitor proteins has been intensely investigated as a central nervous system inhibitor. Although neurite outgrowth inhibitor protein-A (Nogo-A) expression is increased in plasma of patients who have experienced a coronary heart disease, its role in heart disease is not well elucidated. In this study, we discovered a significant increase in Nogo-A expression in diabetic myocardial ischemia reperfusion (MI/R) injury conditions. Accelerated Nogo-A and MI/R injury in diabetic rats was attenuated by tauroursodeoxycholic acid treatment and knockdown of Nogo-A per se is sufficient to decrease endoplasmic reticulum (ER) stress as well as prevents cardiomyocyte apoptosis. We hypothesized that decreased Nogo-A levels might reducing diabetic MI/R injury. Nogo-A interacted with C/EBP homologous protein, suggesting a role for Nogo-A in ER stress during diabetic MI/R. In conclusion, Nogo-A mediated ER stress plays a major role in diabetic MI/R injury, and pathologically altered Nogo-A expression mediates diabetic MI/R injury, suggesting Nogo-A as a novel target for the treatment of diabetic MI/R injury in clinical settings.

 

Comments：

The study suggests that Nogo-A, a protein that is primarily known for its inhibitory role in the central nervous system, plays a significant role in diabetic myocardial ischemia reperfusion (MI/R) injury. The researchers found that Nogo-A expression is increased in diabetic MI/R injury conditions and that this increased expression leads to endoplasmic reticulum (ER) stress and cardiomyocyte apoptosis. However, the study also found that Nogo-A levels can be reduced through treatment with tauroursodeoxycholic acid and knockdown of Nogo-A, which in turn decreased ER stress and prevented cardiomyocyte apoptosis.

The study suggests that Nogo-A interacts with C/EBP homologous protein, which further suggests a role for Nogo-A in ER stress during diabetic MI/R. Based on the findings, the study concludes that Nogo-A mediated ER stress plays a major role in diabetic MI/R injury, and pathologically altered Nogo-A expression mediates diabetic MI/R injury, suggesting Nogo-A as a potential target for the treatment of diabetic MI/R injury in clinical settings.

It is worth noting that further studies will be needed to confirm these findings and to determine the efficacy and safety of targeting Nogo-A for the treatment of diabetic MI/R injury.

Related Products

Cat.No.	Product Name	Information
S3654	Tauroursodeoxycholic Acid (TUDCA)	Tauroursodeoxycholic acid (TUDCA) is the taurine conjugate of ursodeoxycholic acid (UDCA) and acts as a mitochondrial stabilizer and anti-apoptotic agent in several models of neurodegenerative diseases, including AD, Parkinson's diseases (PD), and Huntington's diseases (HD).

Related Targets

Mitochondrial Metabolism